1. Additive for erythrocyte-enriched fluid obtained by adding a hemolysis inhibitor and a surfactant to a blood storage solution in which the hydrophilic lipophilic balance (HLB) of the surfactant is at least 13； the number of oxyethylene groups in the hydrophilic segment of the molecular structure of the surfactant is not less than 20.2. The erythrocyte-enriched liquid supplement according to claim 1, characterized in that the hydrophilic segment of the molecular structure of the surfactant consists of polyoxyethylene sorbitan； and the erythrocyte storage solution is a mixed solution containing mannitol, glucose, adenine, phosphate salt, citrate salt and sodium chloride .3. The erythrocyte-enriched liquid supplement according to claim 1, characterized in that the hydrophilic segment in the molecular structure of the surfactant consists of polyoxyethylene sorbitan； and the erythrocyte storage solution is a mixed solution containing mannitol, glucose, adenine and sodium chloride. The additive for erythrocyte-enriched fluid according to claim 1, characterized in that the hydrophilic segment in the molecular structure of the surfactant consists of polyoxyethylene sorbitan； and the erythrocyte storage solution is a mixed solution containing sorbitol, glucose, adenine, guanosine, phosphate salt and sodium chloride .5. The additive for erythrocyte-enriched fluid according to claim 1, characterized in that the hydrophilic segment in the molecular structure of the surfactant consists of polyoxyethylene； and the erythrocyte storage solution1. Добавка для обогащенной эритроцитами жидкости, полученная путем добавления ингибитора гемолиза и поверхностно-активного вещества в раствор для хранения крови, в которойзначение гидрофильно-липофильного баланса (HLB) поверхностно-активного вещества составляет не менее 13； ачисло оксиэтиленовых групп в гидрофильном сегменте молекулярной структуры поверхностно-активного вещества - не менее 20.2. Добавка для обогащенной эритроцитами жидкост
